127 related articles for article (PubMed ID: 18696412)
1. Gender differences in ondansetron pharmacokinetics in rats.
Yang SH; Yang KH; Lee MG
Biopharm Drug Dispos; 2008 Oct; 29(7):406-13. PubMed ID: 18696412
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic interaction between tamoxifen and ondansetron in rats: non-competitive (hepatic) and competitive (intestinal) inhibition of tamoxifen metabolism by ondansetron via CYP2D subfamily and 3A1/2.
Yang SH; Suh JH; Lee MG
Cancer Chemother Pharmacol; 2010 Feb; 65(3):407-18. PubMed ID: 19504095
[TBL] [Abstract][Full Text] [Related]
3. Effects of cytochrome P450 (CYP) inducers and inhibitors on ondansetron pharmacokinetics in rats: involvement of hepatic CYP2D subfamily and 3A1/2 in ondansetron metabolism.
Yang SH; Lee MG
J Pharm Pharmacol; 2008 Jul; 60(7):853-61. PubMed ID: 18549671
[TBL] [Abstract][Full Text] [Related]
4. Faster clearance of mirodenafil in rats with acute renal failure induced by uranyl nitrate: contribution of increased protein expression of hepatic CYP3A1 and intestinal CYP1A1 and 3A1/2.
Choi YH; Lee YS; Kim TK; Lee BY; Lee MG
J Pharm Pharmacol; 2009 Oct; 61(10):1325-32. PubMed ID: 19814864
[TBL] [Abstract][Full Text] [Related]
5. Effects of enzyme inducers and inhibitors on the pharmacokinetics of metformin in rats: involvement of CYP2C11, 2D1 and 3A1/2 for the metabolism of metformin.
Choi YH; Lee MG
Br J Pharmacol; 2006 Oct; 149(4):424-30. PubMed ID: 16940989
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic interaction between oltipraz and omeprazole in rats: Competitive inhibition of metabolism of oltipraz by omeprazole via CYP1A1 and 3A2, and of omeprazole by oltipraz via CYP1A1/2, 2D1/2, and 3A1/2.
Lee DY; Kim JW; Lee MG
Eur J Pharm Sci; 2007 Dec; 32(4-5):328-39. PubMed ID: 17935951
[TBL] [Abstract][Full Text] [Related]
7. Dose-independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first-pass effects to low bioavailability.
Yang SH; Lee MG
Biopharm Drug Dispos; 2008 Oct; 29(7):414-26. PubMed ID: 18697186
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic drug interactions between ondansetron and tamoxifen in female Sprague-Dawley rats with DMBA-induced mammary tumor.
Yang SH; Suh JH; Lee MG; Kim SH
Anticancer Res; 2013 Feb; 33(2):521-8. PubMed ID: 23393344
[TBL] [Abstract][Full Text] [Related]
9. Effects of bacterial lipopolysaccharide on the pharmacokinetics of metformin in rats.
Choi YH; Lee I; Lee MG
Int J Pharm; 2007 Jun; 337(1-2):194-201. PubMed ID: 17275228
[TBL] [Abstract][Full Text] [Related]
10. Changes in omeprazole pharmacokinetics in rats with diabetes induced by alloxan or streptozotocin: faster clearance of omeprazole due to induction of hepatic CYP1A2 and 3A1.
Lee DY; Lee MG; Shin HS; Lee I
J Pharm Pharm Sci; 2007; 10(4):420-33. PubMed ID: 18261364
[TBL] [Abstract][Full Text] [Related]
11. Effect of ursodeoxycholic acid on the pharmacokinetics of midazolam and CYP3A in the liver and intestine of rats.
Kurosawa S; Uchida S; Ito Y; Yamada S
Xenobiotica; 2009 Feb; 39(2):162-70. PubMed ID: 19255942
[TBL] [Abstract][Full Text] [Related]
12. Effects of sinapic acid on hepatic cytochrome P450 3A2, 2C11, and intestinal P-glycoprotein on the pharmacokinetics of oral carbamazepine in rats: Potential food/herb-drug interaction.
Raish M; Ahmad A; Ansari MA; Alkharfy KM; Ahad A; Al-Jenoobi FI; Al-Mohizea AM; Khan A; Ali N
Epilepsy Res; 2019 Jul; 153():14-18. PubMed ID: 30927680
[TBL] [Abstract][Full Text] [Related]
13. Effects of naringin on the pharmacokinetics of intravenous paclitaxel in rats.
Lim SC; Choi JS
Biopharm Drug Dispos; 2006 Dec; 27(9):443-7. PubMed ID: 17009338
[TBL] [Abstract][Full Text] [Related]
14. Interaction between udenafil and tamsulosin in rats: non-competitive inhibition of tamsulosin metabolism by udenafil via hepatic CYP3A1/2.
Kang HE; Bae SK; Yoo M; Lee DC; Kim YG; Lee MG
Br J Pharmacol; 2009 Mar; 156(6):1009-18. PubMed ID: 19254278
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic interaction between itraconazole and metformin in rats: competitive inhibition of metabolism of each drug by each other via hepatic and intestinal CYP3A1/2.
Choi YH; Lee U; Lee BK; Lee MG
Br J Pharmacol; 2010 Oct; 161(4):815-29. PubMed ID: 20860661
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of omeprazole after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine.
Lee DY; Lee I; Lee MG
Int J Pharm; 2007 Feb; 330(1-2):37-44. PubMed ID: 16997515
[TBL] [Abstract][Full Text] [Related]
17. Effects of cysteine on metformin pharmacokinetics in rats with protein-calorie malnutrition: partial restoration of some parameters to control levels.
Choi YH; Lee I; Lee MG
J Pharm Pharmacol; 2008 Feb; 60(2):153-61. PubMed ID: 18237462
[TBL] [Abstract][Full Text] [Related]
18. Effects of cytochrome P450 inducers and inhibitors on the pharmacokinetics of intravenous furosemide in rats: involvement of CYP2C11, 2E1, 3A1 and 3A2 in furosemide metabolism.
Yang KH; Choi YH; Lee U; Lee JH; Lee MG
J Pharm Pharmacol; 2009 Jan; 61(1):47-54. PubMed ID: 19126296
[TBL] [Abstract][Full Text] [Related]
19. Faster clearance of omeprazole in rats with acute renal failure induced by uranyl nitrate: contribution of increased expression of hepatic cytochrome P450 (CYP) 3A1 and intestinal CYP1A and 3A subfamilies.
Lee DY; Jung YS; Shin HS; Lee I; Kim YC; Lee MG
J Pharm Pharmacol; 2008 Jul; 60(7):843-51. PubMed ID: 18549670
[TBL] [Abstract][Full Text] [Related]
20. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous DA-8159, a new erectogenic, in rats.
Kim YC; Shim HJ; Lee JH; Kim SH; Kwon JW; Kim WB; Lee MG
Biopharm Drug Dispos; 2005 Sep; 26(6):233-41. PubMed ID: 15926192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]